Cancer-Related Mortality Tied to Residential Segregation
Residential racial and economic segregation across US counties is associated with higher cancer mortality, a study suggests.
Lung Cancer
Long-Term Survival With First-Line Nivolumab/Ipilimumab in NSCLC
More than one-third of patients with non-small cell lung cancer treated upfront with nivolumab plus ipilimumab were alive at 3 years.
NSCLC Driving Increase in Stage I Lung Cancer Diagnoses
The incidence of stage I lung cancer increased between 2010 and 2017, according to data from more than 1.4 million US patients with lung cancer.
FDA Passes on Poziotinib for NSCLC With HER2 Exon 20 Insertions
The FDA has issued a complete response letter to Spectrum Pharmaceuticals regarding the new drug application for poziotinib.
Homeopathic Add-On Improves QOL, Survival in Non-Small Cell Lung Cancer
Homeopathic treatment may improve quality of life and survival among patients with stage III-IV non-small cell lung cancer who are receiving chemotherapy.
AEs Related to Antibody-Drug Conjugates Most Common in Breast Cancer
Researchers have characterized treatment-related adverse events associated with antibody-drug conjugates in clinical trials.
Decrease Noted in Lung Cancer Cases Over Past 5 Years
The number of new lung cancer cases decreased 11% over the last 5 years.
Aprepitant Better Than Desloratadine for TKI-Induced Pruritus
A prospective study compared aprepitant with desloratadine for the relief of treatment-induced pruritus in patients with lung cancer treated with EGFR-TKIs.
Are There Factors Associated With Lung Cancer Stage at Diagnosis?
While the rate of late-stage NSCLC diagnosis is improving, more needs to be done to increase survival rates. Are there outside factors that affect the stage at diagnosis, and what can we learn from them?
Medicare Advantage Beneficiaries Have Higher Risk of Death After Cancer Surgeries
Patients with Medicare Advantage insurance plans have an increased risk of death after certain cancer surgeries, a study suggests.
- Loading...
Loading...
Next post in General Oncology
Loading... 
Loading...